Pfizer's Mannitol Injectable is an essential medical solution for managing elevated intracranial pressure and inducing diuresis in numerous clinical scenarios. Packaged in a 50 ml single-dose vial, each contains a 25% concentration of Mannitol, ensuring effective and immediate therapeutic outcomes. Its presentation in a glass fliptop vial assures sterility and quality throughout its shelf life.

This product is available in a box containing 25 vials, making it a practical choice for hospitals and clinics demanding reliable, on-hand treatment options for urgent cases. Mannitol Injection is ideal for patients requiring rapid intervention for head injuries, brain surgery, or to alleviate acute renal conditions. Its high-grade formulation by Pfizer meets rigorous industry standards, underscoring its reliability for healthcare professionals.

Key Features:

• High concentration of 25% Mannitol for effective treatment of elevated intracranial pressure and diuresis.
• Pack of 25 single-dose, 50 ml vials ideal for healthcare facilities with varying patient needs.
• Glass fliptop vials ensure the stability and sterility of the solution until use.

Uses:

• Mannitol Injection, USP, is primarily used to decrease elevated intracranial pressure associated with head trauma, strokes, or brain surgery. It is also used to promote diuresis in patients with reduced urine production and as a renal protective agent.

FAQs:

1. What is Mannitol Injection used for?
Mannitol Injection is used to reduce swelling and pressure inside the eye or around the brain. It is also used to promote diuresis in acute kidney failure.

2. How should Mannitol Injection be stored?
Mannitol Injection should be stored at room temperature away from moisture and light. Keep it tightly closed and out of reach of children.

3. How is Mannitol administered?
Mannitol is administered intravenously under the supervision of qualified health professionals. Dosage varies based on the medical condition and response to treatment.